MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, today announced that it has achieved a second development milestone under its development, commercialization and license agreement with F. Hoffman-La Roche Ltd (Roche), earning an additional $10 million. The development, commercialization and license agreement with Roche covers […]
PerkinElmer’s chemagicTM research instrumentation and kits are now available with the Covaris “truXTRAC FFPE DNA microTUBE Kit for chemagen Technology” for DNA/RNA purification powered by Adaptive Focused Acoustics® (AFA™) technology. “truXTRAC™ FFPE DNA microTUBE Kit for chemagen Technology” rapidly removes paraffin and rehydrates FFPE tissues in aqueous buffer. This preparation is optimized to work with […]
Middleton, Wis.-– Lucigen Corporation announced today that it has signed an exclusive distributorship agreement with Sigma-Aldrich Corporation’s (NASDAQ: SIAL) India subsidiary, Sigma-Aldrich Chemicals Private Ltd., to expand commercialization of life science reagents in India. The synergy between the two companies will provide researchers in India an enhanced customer experience, strong technical support, and easy access […]
GAITHERSBURG, Md.– OpGen, Inc. (Nasdaq:OPGN) today announced the pricing of its initial public offering of 2,850,000 units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock, at a combined price to the public of $6.00 per unit. All of the units are being offered […]
SANTA CLARA, Calif., and BOSTON — Agilent Technologies Inc. (NYSE: A) and Cartagenia today announced that they have signed a definitive agreement under which Agilent will acquire Cartagenia, a leading provider of software and services for clinical genetics and molecular pathology labs. Cartagenia, which has offices in Leuven, Belgium, and Boston, Massachusetts, provides software solutions […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that BGI, the world’s largest genomics organization, has purchased its first PacBio RS II instrument and plans to purchase additional units in order to integrate Single Molecule, Real-Time (SMRT®) Sequencing into its global service business. […]
Shenzhen, China, and Redwood City, California -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that it has expanded its relationship with BGI, the world’s largest genomics organization, to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing […]
Madrid, Spain and Heidelberg, Germany -– SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced a distribution agreement with Cambridge Bioscience for the commercialization of SYGNIS’ proprietary product portfolio in the UK and Ireland. Since the Department for Business, Innovation & Skills, the UK life science industry is one of the world leaders with […]
SAN DIEGO –– Finding genetic causes of progressive supranuclear palsy (PSP) is the goal of a joint research project announced today between Cypher Genomics and the University of Pennsylvania. The research is funded by a grant from CurePSP. PSP is a neurodegenerative brain disease that affects nerve cells that control walking, balance, mobility, vision, speech, […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced the introduction of several new solutions for targeted sequencing applications. The company has introduced a new workflow that combines Roche NimbleGen’s SeqCap EZ enrichment technology with large DNA fragments (up to 6 kb) and PacBio’s […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
